Metraipolis › archive › dc_2772b8901dec
Elacridar Reverses P-gp-Mediated Drug Resistance in Ovarian Cancer Cells in 2D and 3D Culture Models — Europe PMC PMID:41465532
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41465532
- DOI
- 10.3390/ijms262412105
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T15:09:52.762Z
- SHA-256 of the archived text
bd5e533eed4f603c1c9cec7eff78acdc8302632baa1bc8f37678733434d4dea6- Stable URL of this page
https://metraipolis.com/documento/dc_2772b8901dec
How to cite
Elacridar Reverses P-gp-Mediated Drug Resistance in Ovarian Cancer Cells in 2D and 3D Culture Models — Europe PMC PMID:41465532 — Europe PMC (en), https://europepmc.org/article/MED/41465532 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2772b8901dec (Metraipolis archive dc_2772b8901dec, sha256 bd5e533eed4f603c1c9cec7eff78acdc8302632baa1bc8f37678733434d4dea6)
BibTeX
@misc{dc2772b8901dec,
title = {Elacridar Reverses P-gp-Mediated Drug Resistance in Ovarian Cancer Cells in 2D and 3D Culture Models — Europe PMC PMID:41465532},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41465532},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2772b8901dec; sha256 bd5e533eed4f603c1c9cec7eff78acdc8302632baa1bc8f37678733434d4dea6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41465532. Agents can read the archived copy with the MCP tool read_document.